Lite Strategy, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Lite Strategy, Inc. stock issued during period, value, stock options exercised for the quarter ending 2022-03-31 was $360.00K, a 185.71% increase year-over-year.
- Lite Strategy, Inc. stock issued during period, value, stock options exercised for the quarter ending 2021-12-31 was $212.00K, a 1313.33% increase year-over-year.
- Lite Strategy, Inc. stock issued during period, value, stock options exercised for the quarter ending 2021-03-31 was $126.00K.
- Lite Strategy, Inc. stock issued during period, value, stock options exercised for the quarter ending 2020-12-31 was $15.00K.
- Lite Strategy, Inc. stock issued during period, value, stock options exercised for fiscal 2022 was $572.00K, a 72.29% increase from fiscal 2021.
- Lite Strategy, Inc. stock issued during period, value, stock options exercised for fiscal 2021 was $332.00K, a 22.06% increase from fiscal 2020.
- Lite Strategy, Inc. stock issued during period, value, stock options exercised for fiscal 2020 was $272.00K, a 35.55% decline from fiscal 2019.
- Lite Strategy, Inc. stock issued during period, value, stock options exercised for fiscal 2019 was $422.00K, a 28.27% increase from fiscal 2018.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2022-06-30 | $572.00K 10-K · filed 2023-09-26 | |
| 2022-03-31 | $360.00K 10-Q · filed 2023-05-11 | |
| 2021-12-31 | $212.00K 10-Q · filed 2023-05-11 | |
| 2021-06-30 | $332.00K 10-K · filed 2022-09-08 | |
| 2021-03-31 | $126.00K 10-Q · filed 2022-05-23 | |
| 2020-12-31 | $15.00K 10-Q/A · filed 2022-05-23 | |
| 2020-09-30 | $124.00K 10-Q/A · filed 2022-05-23 | |
| 2020-06-30 | $272.00K 10-K · filed 2022-09-08 | |
| 2019-09-30 | $72.00K 10-Q · filed 2021-05-06 | |
| 2019-06-30 | $422.00K 10-K/A · filed 2022-05-23 | |
| 2019-03-31 | $252.00K 10-Q · filed 2020-05-07 | |
| 2018-12-31 | $24.00K 10-Q · filed 2020-05-07 | |
| 2018-09-30 | $43.00K 10-Q · filed 2020-05-07 | |
| 2018-06-30 | $329.00K 10-K · filed 2020-09-09 | |
| 2017-12-31 | $169.00K 10-Q · filed 2019-05-09 | |
| 2017-09-30 | $20.00K 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |